449 related articles for article (PubMed ID: 19095293)
1. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
Hu SW; Holt EW; Husni ME; Qureshi AA
Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
[TBL] [Abstract][Full Text] [Related]
2. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriasis: a pilot study.
Delfino M; Holt EW; Taylor CR; Wittenberg E; Qureshi AA
J Am Acad Dermatol; 2008 Sep; 59(3):439-47. PubMed ID: 18639364
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and construct validity of the parent willingness-to-pay technique for children with juvenile idiopathic arthritis.
Barron AC; Lee TL; Taylor J; Moore T; Passo MH; Graham TB; Griffin TA; Grom AA; Lovell DJ; Brunner HI
Arthritis Rheum; 2004 Dec; 51(6):899-908. PubMed ID: 15593249
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis.
Husted JA; Gladman DD; Farewell VT; Cook RJ
Arthritis Rheum; 2001 Apr; 45(2):151-8. PubMed ID: 11324779
[TBL] [Abstract][Full Text] [Related]
5. Reliability of self-reported willingness-to-pay and annual income in patients treated for toenail onychomycosis.
Cham PM; Chen SC; Grill JP; Jonk YC; Warshaw EM
Br J Dermatol; 2007 May; 156(5):922-8. PubMed ID: 17459013
[TBL] [Abstract][Full Text] [Related]
6. Willingness-to-pay and quality of life in patients with vitiligo.
Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Instrument Based on Eight Health Related Quality of Life Domains for Measuring of Willingness to Pay for Psoriasis Treatment.
Dobrev HP; Atanasov NG; Dimitrova DD
Folia Med (Plovdiv); 2017 Sep; 59(3):326-335. PubMed ID: 28976906
[TBL] [Abstract][Full Text] [Related]
8. Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective.
Fautrel B; Clarke AE; Guillemin F; Adam V; St-Pierre Y; Panaritis T; Fortin PR; Menard HA; Donaldson C; Penrod JR
J Rheumatol; 2005 Mar; 32(3):443-53. PubMed ID: 15742435
[TBL] [Abstract][Full Text] [Related]
9. Willingness to pay for health improvements of physical activity on prescription.
Romé A; Persson U; Ekdahl C; Gard G
Scand J Public Health; 2010 Mar; 38(2):151-9. PubMed ID: 20064920
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey.
Brodszky V; Péntek M; Bálint PV; Géher P; Hajdu O; Hodinka L; Horváth G; Koó E; Polgár A; Seszták M; Szántó S; Ujfalussy I; Gulácsi L
Scand J Rheumatol; 2010 Aug; 39(4):303-9. PubMed ID: 20166848
[TBL] [Abstract][Full Text] [Related]
11. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone.
Rosen CF; Mussani F; Chandran V; Eder L; Thavaneswaran A; Gladman DD
Rheumatology (Oxford); 2012 Mar; 51(3):571-6. PubMed ID: 22157469
[TBL] [Abstract][Full Text] [Related]
12. Willingness-to-pay for community-based insurance in Burkina Faso.
Dong H; Kouyate B; Cairns J; Mugisha F; Sauerborn R
Health Econ; 2003 Oct; 12(10):849-62. PubMed ID: 14508869
[TBL] [Abstract][Full Text] [Related]
13. Socioeconomic differences in preferences and willingness-to-pay for insulin delivery systems in type 1 and type 2 diabetes.
Guimarães C; Marra CA; Colley L; Gill S; Simpson S; Meneilly G; Queiroz RH; Lynd LD
Diabetes Technol Ther; 2009 Sep; 11(9):567-73. PubMed ID: 19764835
[TBL] [Abstract][Full Text] [Related]
14. Willingness to pay to assess patient preferences for therapy in a Canadian setting.
Marra CA; Frighetto L; Goodfellow AF; Wai AO; Chase ML; Nicol RE; Leong CA; Tomlinson S; Ferreira BM; Jewesson PJ
BMC Health Serv Res; 2005 Jun; 5():43. PubMed ID: 15941474
[TBL] [Abstract][Full Text] [Related]
15. Willingness-to-pay stated preferences in cutaneous lupus erythematosus: a pilot study.
Liu SW; Tkachenko E; Lam C; Alsarheed A; Cobos G; Lo K; Femia A; Qureshi AA; Vleugels RA
Arch Dermatol Res; 2020 Sep; 312(7):527-531. PubMed ID: 31773259
[TBL] [Abstract][Full Text] [Related]
16. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
Franic DM; Pathak DS; Gafni A
J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
[TBL] [Abstract][Full Text] [Related]
17. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
[TBL] [Abstract][Full Text] [Related]
18. Valuing the benefits of a health intervention using three different approaches to contingent valuation: re-treatment of mosquito bed-nets in Nigeria.
Onwujekwe O; Fox-Rushby J; Hanson K
J Health Serv Res Policy; 2004 Apr; 9(2):67-75. PubMed ID: 15099453
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
20. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
King JT; Tsevat J; Lave JR; Roberts MS
Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
